Physician profile
Danqing Hu
NPI 1578927117
$10,740.04
in general payments reported to CMS, 2019-2025
8 companies · $32.37 in 2025
The $32.37 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $10K · 2021: $116 · 2022: $301 · 2023: $64.69 · 2024: $91.33 · 2025: $32.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $188.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $10,000.00 | 2020 | |
| Nevro Corp. | $257.86 | 2019-2022 | |
| Grt US Holding, INC. | $170.00 | 2022 | |
| Boston Scientific Corporation | $144.93 | 2022-2024 | Wavewriter Alpha Prime 16 |
| Stryker Corporation | $56.96 | 2021 | |
| Emd Serono, INC. | $41.25 | 2023 | Mavenclad |
| Medtronic, INC. | $36.67 | 2023-2024 | Intellis Adaptivestim, Accurian |
| Averitas Pharma INC. | $32.37 | 2025 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danqing Hu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.